CGS encourages responsible uses and effecitve governance of human genetic and assisted reproductive technologies

Featured

Biopolitical Times

What might have been the story of the year turned out to be a disappointment. On February 14th, the National Academies delivered a valentine to those who want to commit germline gene editing. Its much anticipated report, Human Genome Editing: Science, Ethics, and Governance concluded that scientists should “proceed with caution.” This was the first time that human germline modification has ever been given a green light by a comparable body – the U.S. National Academies is an influential non-governmental...

Biopolitical Times
Are heroes born or are they raised? This is a classic example of the “nature versus nurture” debate. Anyone who considers having children wonders if their baby will be healthy, whether they can afford to pay for extra-curricular activities, how they will handle a child who is bullied or who bullies, how they can help their kid be secure and self-motivated....
Biopolitical Times

On Tuesday, November 14, the Senate Health, Education, Labor, and Pensions (HELP) Committee held a hearing on “Gene Editing:...

Biopolitical Times

This year marks the 20th anniversary of the Oviedo Convention, the only international, legally binding treaty for human rights protection...

Biopolitical Times

What might have been the story of the year turned out to be a disappointment. On February 14th, the National...

The November 2017 issue of Nature Biotechnology included a special focus on “Humans 2.0.” The articles (currently available...

Are heroes born or are they raised? This is a classic example of the “nature versus nurture” debate. Anyone who...

News

Aggregated News

EXCLUSIVE: Demand for IVF in China has surged since the one-child policy was scrapped, but unmarried women are denied access. SBS News follows one hopeful mother on her international journey to start a family.

Chen Huang always wanted a baby....

Aggregated News

In late 2012, French microbiologist Emmanuelle Charpentier approached a handful of American scientists about starting a company, a Crispr company. They included UC Berkeley’s Jennifer Doudna, George Church at Harvard University, and his former postdoc Feng Zhang of the Broad...

Aggregated News

First, let me tell you how smart I am. So smart. My fifth-grade teacher said I was gifted in mathematics and, looking back, I have to admit that she was right. I’ve properly grasped the character of metaphysics as...

Aggregated News

It seems hard to fathom that scientific progress has advanced to a point where it’s suddenly possible for people to undertake something as complicated as gene therapy outside the safety and confines of a well-funded lab, but it has. In...

Video

Talking Biopolitics 2017-2018 with Shobita Parthasarathy and Tania Simoncelli
Talking Biopolitics 2017-2018 with Ben Hurlbut and Patricia Williams
Gene Editing and the Future of Reproductive Justice